Yi-Shing Shieh

Dr. Yi-Shing Shieh


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Oral Oncology
Verified
Journal Article
Closed access
KCKuo-Chou Chiu
Kuo-Chou Chiu
CLChien-Hsing Lee
Chien-Hsing Lee
SLShyun-Yeu Liu
Shyun-Yeu Liu
YCYu-Ting Chou
Yu-Ting Chou
RHRen-Yeong Huang
Ren-Yeong Huang
YSYi-Shing Shieh
Yi-Shing Shieh

1 November 2020 in Neoplasia
Verified
Journal Article
Open access
HPHsuan-Yu Peng
Hsuan-Yu Peng
JHJenn-Ren Hsiao
Jenn-Ren Hsiao
SCSung-Tau Chou
Sung-Tau Chou
YHYuan-Ming Hsu
Yuan-Ming Hsu
GWGuan-Hsun Wu
Guan-Hsun Wu
SSShine-Gwo Shiah
Shine-Gwo Shiah
• Down-regulation of CISH in OSCC tissues and cell lines. • CISH mediates cellular functions through STAT3 inhibition. • MiR-944 regulates cellular functions through direct binding of CISH. • Cigarette smoking-mediated miR-944/CISH/STAT3 axis plays a role in oral carcinogenesis.

1 March 2020 in Archives of Oral Biology
Verified
Journal Article
Closed access
CHChia-Chen Hsu
Chia-Chen Hsu
KTKuo-Yang Tsai
Kuo-Yang Tsai
YSYu-Fu Su
Yu-Fu Su
CCChu-Yen Chien
Chu-Yen Chien
YCYing-Chen Chen
Ying-Chen Chen
YSYi-Shing Shieh
Yi-Shing Shieh

1 February 2012 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
CLChien-Hsing Lee
Chien-Hsing Lee
NCNain-Feng Chu
Nain-Feng Chu
YSYi-Shing Shieh
Yi-Shing Shieh
YHYi-Jen Hung
Yi-Jen Hung

13 August 2021 in Cells
Verified
Journal Article
Open access
PDF file
CCChu-Yen Chien
Chu-Yen Chien
YCYing-Chen Chen
Ying-Chen Chen
CHChia-Chen Hsu
Chia-Chen Hsu
YCYu-Ting Chou
Yu-Ting Chou
SSShine-Gwo Shiah
Shine-Gwo Shiah
YSYi-Shing Shieh
Yi-Shing Shieh
Cigarette smoking is a significant risk factor for the development and progression of oral cancer. Previous studies have reported an association between nicotine and malignancy in oral cancer. Recent studies have also demonstrated that nicotine can induce endoplasmic reticulum (ER) stress in tumor cells. Binding immunoglobulin protein (BiP) acts as a master regulator of ER stress and is frequently overexpressed in oral cancer cell lines and tissues. However, the effect of nicotine on BiP in oral cancer is unknown. Therefore, this study aimed to evaluate the role of BiP and its underlying regulatory mechanisms in nicotine-induced oral cancer progression. Our results showed that nicotine significantly induced the expression of BiP in time- and dose-dependent manners in oral squamous cell carcinoma (OSCC) cells. In addition, BiP was involved in nicotine-mediated OSCC malignancy, and depletion of BiP expression remarkably suppressed nicotine-induced malignant behaviors, including epithelial–mesenchymal transition (EMT) change, migration, and invasion. In vivo, BiP silencing abrogated nicotine-induced tumor growth and EMT switch in nude mice. Moreover, nicotine stimulated BiP expression through the activation of the YAP-TEAD transcriptional complex. Mechanistically, we observed that nicotine regulated YAP nuclear translocation and its interaction with TEAD through α7-nAChR-Akt signaling, subsequently resulting in increased TEAD occupancy on the HSPA5 promoter and elevated promoter activity. These observations suggest that BiP is involved in nicotine-induced oral cancer malignancy and may have therapeutic potential in tobacco-related oral cancer.

1 January 2020 in Medicine
Verified
Journal Article
Open access
KLKuei-Chen Lee
Kuei-Chen Lee
YWYung-Tsan Wu
Yung-Tsan Wu
WCWu-Chien Chien
Wu-Chien Chien
CCChi-Hsiang Chung
Chi-Hsiang Chung
LCLiang-Cheng Chen
Liang-Cheng Chen
YSYi-Shing Shieh
Yi-Shing Shieh
The coexistence of low back pain (LBP) and temporomandibular disorder (TMD) has often been noted clinically. However, studies of the association between these two conditions involving a large population with longitudinal evidences are lacking. Therefore, the study aimed to investigate the association between LBP and TMD in a nationwide-matched cohort population with a 15-year follow-up. Data of 65,121 patients newly diagnosed with LBP were analyzed, along with those of 195,363 (1:3) sex- and age-matched controls. Multivariate Cox regression analysis was used to determine TMD risk between the LBP and non-LBP groups. Kaplan-Meier method was used for determining the cumulative risk of first-onset TMD between groups, with a 15-year follow-up. The LBP group was more likely to develop first-onset TMD (adjusted hazards ratio (HR) = 1.561, P < .001), after adjusting for demographic variables and comorbidities. The risk factors for TMD were LBP, young age, higher insured premium, and osteoporosis. In the subgroup analysis, the LBP group had a higher risk of TMD than the non-LBP group in all stratifications. LBP is the risk factor contributing to the development of first-onset TMD. Therefore, clinicians should be reminded to manage LBP disorders concurrently when treating TMD.